TY - JOUR
T1 - Cardiac Rehabilitation Availability and Density around the Globe
AU - Turk-Adawi, Karam
AU - Supervia, Marta
AU - Lopez-Jimenez, Francisco
AU - Pesah, Ella
AU - Ding, Rongjing
AU - Britto, Raquel R.
AU - Bjarnason-Wehrens, Birna
AU - Derman, Wayne
AU - Abreu, Ana
AU - Babu, Abraham S.
AU - Santos, Claudia Anchique
AU - Jong, Seng Khiong
AU - Cuenza, Lucky
AU - Yeo, Tee Joo
AU - Scantlebury, Dawn
AU - Andersen, Karl
AU - Gonzalez, Graciela
AU - Giga, Vojislav
AU - Vulic, Dusko
AU - Vataman, Eleonora
AU - Cliff, Jacqueline
AU - Kouidi, Evangelia
AU - Yagci, Ilker
AU - Kim, Chul
AU - Benaim, Briseida
AU - Estany, Eduardo Rivas
AU - Fernandez, Rosalia
AU - Radi, Basuni
AU - Gaita, Dan
AU - Simon, Attila
AU - Chen, Ssu Yuan
AU - Roxburgh, Brendon
AU - Martin, Juan Castillo
AU - Maskhulia, Lela
AU - Burdiat, Gerard
AU - Salmon, Richard
AU - Lomelí, Hermes
AU - Sadeghi, Masoumeh
AU - Sovova, Eliska
AU - Hautala, Arto
AU - Tamuleviciute-Prasciene, Egle
AU - Ambrosetti, Marco
AU - Neubeck, Lis
AU - Asher, Elad
AU - Kemps, Hareld
AU - Eysymontt, Zbigniew
AU - Farsky, Stefan
AU - Hayward, Jo
AU - Prescott, Eva
AU - Dawkes, Susan
AU - Santibanez, Claudio
AU - Zeballos, Cecilia
AU - Pavy, Bruno
AU - Kiessling, Anna
AU - Sarrafzadegan, Nizal
AU - Baer, Carolyn
AU - Thomas, Randal
AU - Hu, Dayi
AU - Grace, Sherry L.
N1 - Funding Information:
This research was supported by a grant from York University 's Faculty of Health. The funder had no role in study design, data collection, data analysis, interpretation or writing of the report.
Funding Information:
This research was supported by a grant from York University's Faculty of Health. The funder had no role in study design, data collection, data analysis, interpretation or writing of the report. On behalf of the International Council of Cardiovascular Prevention and Rehabilitation through which this study was undertaken, we are grateful to others who collaborated with us to identify and reach programs in their country, namely: Dr. Alexander Aleksiev, Dr. Artur Herdy, Dr. Robyn Gallagher, Dr. Josef Niebauer, Dr. Martin Heine, Maria Mooney, Dr. Borut Jug, Dr. Aashish Contractor, Dr. Batgerel Oidov, Dr. Henrik Schirmer, and Dr. Fernando Sepuvelda. We also thank Ms. Anfal Adawi for assisting with display items. We thank the following associations for assisting with program identification: Korean Academy of Cardiopulmonary Rehabilitation Medicine, the British Association of Cardiovascular Prevention and Rehabilitation, the International Society of Physical and Rehabilitation Medicine, Associação Brasileira de Fisioterapia Cardiorrespiratória e Fisioterapia em Terapia Intensiva (ASSOBRAFIR), the Australian Cardiovascular Health and Rehabilitation Association (ACRA) and World Heart Federation (who also formally endorsed the study protocol). We are also grateful to Dr. Carmen Terzic who shared the CR program survey administered in Latin America with the investigative team; this work informed development of the survey administered in this study. Finally, we would like to thank York University for supporting this study by a research grant through York University's Faculty of Health.
Publisher Copyright:
© 2019
PY - 2019/8
Y1 - 2019/8
N2 - Background: Despite the epidemic of cardiovascular disease and the benefits of cardiac rehabilitation (CR), availability is known to be insufficient, although this is not quantified. This study ascertained CR availability, volumes and its drivers, and density. Methods: A survey was administered to CR programs globally. Cardiac associations and local champions facilitated program identification. Factors associated with volumes were assessed using generalized linear mixed models, and compared by World Health Organization region. Density (i.e. annual ischemic heart disease [IHD] incidence estimate from Global Burden of Disease study divided by national CR capacity) was computed. Findings: CR was available in 111/203 (54.7%) countries; data were collected in 93 (83.8% country response; N = 1082 surveys, 32.1% program response rate). Availability by region ranged from 80.7% of countries in Europe, to 17.0% in Africa (p < .001). There were 5753 programs globally that could serve 1,655,083 patients/year, despite an estimated 20,279,651 incident IHD cases globally/year. Volume was significantly greater where patients were systematically referred (odds ratio [OR] = 1.36, 95% confidence interval [CI] = 1.35–1.38) and programs offered alternative models (OR = 1.05, 95%CI = 1.04–1.06), and significantly lower with private (OR = .92, 95%CI = .91–.93) or public (OR = .83, 95%CI = .82–84) funding compared to hybrid sources. Median capacity (i.e., number of patients a program could serve annually) was 246/program (Q25-Q75 = 150–390). The absolute density was one CR spot per 11 IHD cases in countries with CR, and 12 globally. Interpretation: CR is available in only half of countries globally. Where offered, capacity is grossly insufficient, such that most patients will not derive the benefits associated with participation.
AB - Background: Despite the epidemic of cardiovascular disease and the benefits of cardiac rehabilitation (CR), availability is known to be insufficient, although this is not quantified. This study ascertained CR availability, volumes and its drivers, and density. Methods: A survey was administered to CR programs globally. Cardiac associations and local champions facilitated program identification. Factors associated with volumes were assessed using generalized linear mixed models, and compared by World Health Organization region. Density (i.e. annual ischemic heart disease [IHD] incidence estimate from Global Burden of Disease study divided by national CR capacity) was computed. Findings: CR was available in 111/203 (54.7%) countries; data were collected in 93 (83.8% country response; N = 1082 surveys, 32.1% program response rate). Availability by region ranged from 80.7% of countries in Europe, to 17.0% in Africa (p < .001). There were 5753 programs globally that could serve 1,655,083 patients/year, despite an estimated 20,279,651 incident IHD cases globally/year. Volume was significantly greater where patients were systematically referred (odds ratio [OR] = 1.36, 95% confidence interval [CI] = 1.35–1.38) and programs offered alternative models (OR = 1.05, 95%CI = 1.04–1.06), and significantly lower with private (OR = .92, 95%CI = .91–.93) or public (OR = .83, 95%CI = .82–84) funding compared to hybrid sources. Median capacity (i.e., number of patients a program could serve annually) was 246/program (Q25-Q75 = 150–390). The absolute density was one CR spot per 11 IHD cases in countries with CR, and 12 globally. Interpretation: CR is available in only half of countries globally. Where offered, capacity is grossly insufficient, such that most patients will not derive the benefits associated with participation.
KW - Capacity
KW - Cardiac rehabilitation
KW - Density
KW - Global health
KW - Health services
KW - Preventive cardiology
UR - http://www.scopus.com/inward/record.url?scp=85068157910&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85068157910&partnerID=8YFLogxK
U2 - 10.1016/j.eclinm.2019.06.007
DO - 10.1016/j.eclinm.2019.06.007
M3 - Article
AN - SCOPUS:85068157910
SN - 2589-5370
VL - 13
SP - 31
EP - 45
JO - EClinicalMedicine
JF - EClinicalMedicine
ER -